Cargando…
COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in Germany
OBJECTIVE: We aimed to estimate the incidence of cerebral sinus and venous thrombosis (CVT) within 1 month from first dose administration and the frequency of vaccine‐induced immune thrombotic thrombocytopenia (VITT) as the underlying mechanism after vaccination with BNT162b2, ChAdOx1, and mRNA‐1273...
Autores principales: | Schulz, Jörg B., Berlit, Peter, Diener, Hans‐Christoph, Gerloff, Christian, Greinacher, Andreas, Klein, Christine, Petzold, Gabor C., Piccininni, Marco, Poli, Sven, Röhrig, Rainer, Steinmetz, Helmuth, Thiele, Thomas, Kurth, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427115/ https://www.ncbi.nlm.nih.gov/pubmed/34288044 http://dx.doi.org/10.1002/ana.26172 |
Ejemplares similares
-
Neurologische Nebenwirkungen der COVID-19-Impfung
por: Diener, Hans-Christoph, et al.
Publicado: (2022) -
COVID-19(„coronavirus disease 2019“)-Impfung: NNTV („number needed to vaccinate“) – Was ist das und was heißt hier „unimpressive“?
por: Gerloff, Christian, et al.
Publicado: (2021) -
Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
por: Graf, Tilmann, et al.
Publicado: (2021) -
Cerebral venous thrombosis
por: Moraes, Anisio Adalio de Azevedo, et al.
Publicado: (2022) -
Cerebral venous and sinus thrombosis
por: Boucelma, Malika
Publicado: (2013)